Development of cell-based immunoassays to measure type I collagen in cultured fibroblasts

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 11, 2010, Pages 1808-1815

  Jones, Brian ^a   Bucks, Christine ^a   Wilkinson, Patrick ^a   Pratta, Michael ^a   Farrell, Francis ^a   Sivakumar, Pitchumani ^a  

^a CENTOCOR INC   (United States)

Author keywords

Collagen; Extracellular matrix; Fibroblasts; Fibrosis; TGF

Indexed keywords

COLLAGEN TYPE 1; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ASSAY; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOASSAY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; IMMUNOASSAY; MICROSCOPY, FLUORESCENCE; RADIOIMMUNOASSAY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77957277152     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.07.011     Document Type: Article

References (38)

1. Biagini G., Ballardini G. Liver fibrosis and extracellular matrix. J Hepatol 1989, 8:115-124.
2. Booth B.A., Uitto J. Collagen biosynthesis by human skin fibroblasts. III. The effects of ascorbic acid on procollagen production and prolyl hydroxylase activity. Biochim Biophys Acta 1981, 675:117-122.
3. Chesnutt A.N., Matthay M.A., Tibayan F.A., Clark J.G. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997, 156:840-845.
4. Cushing M.C., Mariner P.D., Liao J.T., Sims E.A., Anseth K.S. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008, 22:1769-1777.
5. Davidson J.M., Berg R.A. Posttranslational events in collagen biosynthesis. Methods Cell Biol 1981, 23:119-136.
6. de Paepe A. The Ehlers-Danlos syndrome: a heritable collagen disorder as cause of bleeding. Thromb Haemost 1996, 75:379-386.
7. Egorina E.M., Sovershaev M.A., Bjorkoy G., Gruber F.X., Olsen J.O., Parhami-Seren B., et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol 2005, 25:1493-1498.
8. Egorina E.M., Sovershaev M.A., Osterud B. In-cell Western assay: a new approach to visualize tissue factor in human monocytes. J Thromb Haemost 2006, 4:614-620.
9. Gardner J.L., Turner S.M., Bautista A., Lindwall G., Awada M., Hellerstein M.K. Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1695-1705.
10. Grinnell F., Fukamizu H., Pawelek P., Nakagawa S. Collagen processing, crosslinking, and fibril bundle assembly in matrix produced by fibroblasts in long-term cultures supplemented with ascorbic acid. Exp Cell Res 1989, 181:483-491.
11. Heino J. The collagen family members as cell adhesion proteins. Bioessays 2007, 29:1001-1010.
12. Kadler K. Matrix loading: assembly of extracellular matrix collagen fibrils during embryogenesis. Birth Defects Res C Embryo Today 2004, 72:1-11.
13. Kadler K.E., Baldock C., Bella J., Boot-Handford R.P. Collagens at a glance. J Cell Sci 2007, 120:1955-1958.
14. Kivirikko K.I. Collagen biosynthesis: a mini-review cluster. Matrix Biol 1998, 16:355-356.
15. Kondo A., Ishikawa O., Okada K., Miyachi Y., Abe S., Kuboki Y. Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling. Anal Biochem 1997, 252:255-259.
16. Lam S., van der Geest R.N., Verhagen N.A., Daha M.R., van Kooten C. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway. Nephrol Dial Transplant 2004, 19:1694-1701.
17. Last J.A., Armstrong L.G., Reiser K.M. Biosynthesis of collagen crosslinks. Int J Biochem 1990, 22:559-564.
18. McAnulty R.J., Campa J.S., Cambrey A.D., Laurent G.J. The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta 1991, 1091:231-235.
19. Melkko J., Kauppila S., Niemi S., Risteli L., Haukipuro K., Jukkola A., et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996, 42:947-954.
20. Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol 2003, 22:15-24.
21. Nacher M., Serrano S., Marinoso M.L., Garcia M.C., Bosch J., Diez A., et al. In vitro synthesis of type I collagen: quantification of carboxyterminal propeptide of procollagen type I versus tritiated proline incorporation. Calcif Tissue Int 1999, 64:224-228.
22. Nimni M.E. Collagen: structure, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum 1983, 13:1-86.
23. Olsen D.R., Chu M.L., Uitto J. Expression of basement membrane zone genes coding for type IV procollagen and laminin by human skin fibroblasts in vitro: elevated alpha 1 (IV) collagen mRNA levels in lipoid proteinosis. J Invest Dermatol 1988, 90:734-738.
24. Orum O., Hansen M., Jensen C.H., Sorensen H.A., Jensen L.B., Horslev-Petersen K., et al. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone 1996, 19:157-163.
25. Ottani V., Raspanti M., Ruggeri A. Collagen structure and functional implications. Micron 2001, 32:251-260.
26. Prockop D.J., Colige A., Helminen H., Khillan J.S., Pereira R., Vandenberg P. Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies. J Bone Miner Res 1993, 8(Suppl. 2):S489-492.
27. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994, 8:823-831.
28. Ricard-Blum S., Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol (Paris) 2005, 53:430-442.
29. Rishikof D.C., Kuang P.P., Subramanian M., Goldstein R.H. Methods for measuring type I collagen synthesis in vitro. Methods Mol Med 2005, 117:129-140.
30. Risteli J., Niemi S., Kauppila S., Melkko J., Risteli L. Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand Suppl 1995, 266:183-188.
31. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006, 3:413-417.
32. Shimonishi M., Sato J., Takahashi N., Komatsu M. Expression of type IV collagen and laminin at the interface between epithelial cells and fibroblasts from human periodontal ligament. Eur J Oral Sci 2005, 113:34-40.
33. Shoshan S. Collagen in scar formation. Agents Actions Suppl 1979, 67-72.
34. Tredget E.E., Falk N., Scott P.G., Hogg A.M., Burke J.F. Determination of 4-hydroxyproline in collagen by gas chromatography/mass spectrometry. Anal Biochem 1990, 190:259-265.
35. Vogel W.F. Collagen-receptor signaling in health and disease. Eur J Dermatol 2001, 11:506-514.
36. Yamada H., Aida T., Taguchi K., Asano G. Expression of type III and IV procollagen, prolyl 4-hydroxylase mRNAs in fibrotic human liver. Nippon Rinsho 1993, 51:423-427.
37. Yata Y., Scanga A., Gillan A., Yang L., Reif S., Breindl M., et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 2003, 37:267-276.
38. Zhang K., Garner W., Cohen L., Rodriguez J., Phan S. Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 1995, 104:750-754.